Atomoxetine and Headache - a phase IV clinical study of FDA data

Summary:

Headache is reported as a side effect among people who take Atomoxetine (atomoxetine), especially for people who are male, 10-19 old, have been taking the drug for 1 - 6 months also take Vyvanse, and have Autism spectrum disorder.

The phase IV clinical study analyzes which people have Headache when taking Atomoxetine. It is created by eHealthMe based on reports of 1,183 people who have side effects when taking Atomoxetine from the FDA, and is updated regularly.

What is Atomoxetine?

Atomoxetine has active ingredients of atomoxetine. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 1,363 Atomoxetine users. Check the latest studies of Atomoxetine.

What is Headache?

Headache (pain in head) is found to be associated with 3,746 drugs and 5,768 conditions by eHealthMe. Check the latest studies of Headache.

On Jul, 10, 2026

1,183 people reported to have side effects when taking Atomoxetine.
Among them, 82 people (6.93%) have Headache.

Among these 82 people:

How long have people been on Atomoxetine when they have Headache? *

What is the gender of people who have Headache when taking Atomoxetine? *

female: 30.3 %
male: 69.7 %

What is the age of people who have Headache when taking Atomoxetine? *

What are other drugs people take besides Atomoxetine? *

Sertraline: 10 people, 12.20%
Vyvanse: 10 people, 12.20%
Adderall: 9 people, 10.98%
Lisdexamfetamine Dimesylate: 9 people, 10.98%
Fluoxetine: 6 people, 7.32%
Strattera: 5 people, 6.10%
Concerta: 4 people, 4.88%
Biotin: 4 people, 4.88%
Promethazine: 4 people, 4.88%
Sodium Chloride 0.9%: 3 people, 3.66%

What are other side effects people have besides Headache? *

Irritability: 31 people, 37.80%
Drug Ineffective: 20 people, 24.39%
Autism Spectrum Disorder (developmental disabilities that can cause significant social, communication and behavioural challenges): 17 people, 20.73%
Weight Increased: 16 people, 19.51%
Insomnia (sleeplessness): 16 people, 19.51%
Dizziness: 14 people, 17.07%
Nausea (feeling of having an urge to vomit): 13 people, 15.85%
Drowsiness: 11 people, 13.41%
Emotional Disorder: 11 people, 13.41%
Electrocardiogram Qt Prolonged: 11 people, 13.41%

What are the existing conditions these people have? *

Autism Spectrum Disorder (developmental disabilities that can cause significant social, communication and behavioural challenges): 14 people, 17.07%
Stress And Anxiety: 6 people, 7.32%
Obsessive-Compulsive Disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;): 5 people, 6.10%
Weight Decreased: 4 people, 4.88%
Disturbance In Attention: 4 people, 4.88%
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (long lasting infection of nerves outside brain and spinal cord): 3 people, 3.66%
Depression: 2 people, 2.44%
Insomnia (sleeplessness): 2 people, 2.44%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 2.44%
Personality Change: 2 people, 2.44%

* Approximation only. Some reports may have incomplete information.

Do you take Atomoxetine and have Headache?

- Check whether Headache is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atomoxetine:

Atomoxetine (1,363 reports)

Headache treatments and more:

Headache (756,642 reports)

Browse all side effects of Atomoxetine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Headache:

Headache (3,746 drugs)

Browse all the conditions that are associated with Headache:

Headache (5,768 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on atomoxetine (the active ingredients of Atomoxetine) and Atomoxetine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.